FTC “Made in U.S.A.”
This article was originally published in The Tan Sheet
Executive Summary
Commission approves five final consent orders Feb. 22 requiring private label OTC analgesic manufacturers who use imported active ingredients to disclose such details when an origin statement is included on product labeling (1"The Tan Sheet" Nov. 12, 2001, p. 3). FTC clears consent orders with Perrigo, Leiner, Pharmaceutical Formulations, Inc., LNK International, A&S Pharmaceutical in separate 5-0 votes...